CVE-2021-28645

Description

An incorrect permission assignment vulnerability in Trend Micro Apex One, Apex One as a Service and OfficeScan XG SP1 could allow a local attacker to escalate privileges on affected installations. Please note: an attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.07%
Vendor Advisory trendmicro.com Vendor Advisory trendmicro.com
Affected: Trend Micro Trend Micro Apex One
Affected: Trend Micro Trend Micro OfficeScan
Published at:
Updated at:

References

Link Tags
https://success.trendmicro.com/solution/000286019 vendor advisory
https://success.trendmicro.com/solution/000286157 vendor advisory
https://www.zerodayinitiative.com/advisories/ZDI-21-402/ vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2021-28645?
CVE-2021-28645 has been scored as a high severity vulnerability.
How to fix CVE-2021-28645?
To fix CVE-2021-28645, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-28645 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-28645 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-28645?
CVE-2021-28645 affects Trend Micro Trend Micro Apex One , Trend Micro Trend Micro OfficeScan.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.